Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1
2019 · Journal of Experimental & Clinical Cancer Research · 105 citations
https://doi.org/10.1186/s13046-019-1420-8
L
Luigi Portella
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
133
Papers
1.7K
Citations
22
h-index
32
i10-index
Luigi Portella is an academic researcher from Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale". The author has contributed to research in topics: Prostate Cancer Treatment and Research & Cancer Immunotherapy and Biomarkers & Chemokine receptors and signaling. The author has an h-index of 22, co-authored 114 publications.
ORCID: 0000-0002-8679-3309Papers by this author
worksA novel CXCR4-targeted near-infrared (NIR) fluorescent probe (Peptide R-NIR750) specifically detects CXCR4 expressing tumors
2017 · Scientific Reports · 19 citations
https://doi.org/10.1038/s41598-017-02818-6
Hepatocellular carcinoma (HCC) tumor microenvironment is more suppressive than colorectal cancer liver metastasis (CRLM) tumor microenvironment
2023 · Hepatology International · 18 citations
https://doi.org/10.1007/s12072-023-10537-6
Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocol
2019 · BMC Cancer · 16 citations
https://doi.org/10.1186/s12885-019-6109-z
Targeting CXCR4 impaired T regulatory function through PTEN in renal cancer patients
2024 · British Journal of Cancer · 15 citations
https://doi.org/10.1038/s41416-024-02702-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat